Skip to content

Clinical trials

Phase 3 Diabetes Mellitus, Type 1 trials in Spain

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Diabetes Mellitus, Type 1 Phase: Phase 3 Country / region: Spain Clear all

41 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20023
20052
20062
20071
20082
20092
20102
20121
20131
20143
20154
20161
20175
20181
20193
20211
20221
20241
20253
20262

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed29
Terminated6
Recruiting3
Active, not recruiting2
Withdrawn1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Eli Lilly and Company10
Novo Nordisk A/S6
Sanofi4
Mannkind Corporation3
Andromeda Biotech Ltd.2
Boehringer Ingelheim2
Gan and Lee Pharmaceuticals, USA2
Ixaka Ltd2
Lexicon Pharmaceuticals2
AstraZeneca1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Diabetes Mellitus, Type 141
Diabetes Mellitus12
Diabetes Mellitus, Type 25
Cardiovascular Diseases2
Chronic Limb-Threatening Ischemia2
Insulin Resistance2
Obesity2
Overweight2
Peripheral Arterial Disease2
Asthma1

Trials

Showing 1 to 25 of 41. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.